Recent immunohistochemical studies revealed that the frequency of positive CD10 stromal expression in tumors was significantly correlated with the prognosis of patients with breast cancers [18] as well as the invasion and metastasis of gastric cancers [19]. This evidence concerns the gene MME and breast carcinoma.